|
|
|
Volumn , Issue 57, 2004, Pages 1-4
|
|
Ximelagatran for prevention and treatment of venous thromboembolism.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
AZETIDINE DERIVATIVE;
LOW MOLECULAR WEIGHT HEPARIN;
WARFARIN;
ARTICLE;
CANADA;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG APPROVAL;
EUROPE;
EVIDENCE BASED MEDICINE;
HUMAN;
ORAL DRUG ADMINISTRATION;
ORTHOPEDIC SURGERY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
VEIN THROMBOSIS;
ADMINISTRATION, ORAL;
ANTICOAGULANTS;
AZETIDINES;
CANADA;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG APPROVAL;
EUROPE;
EVIDENCE-BASED MEDICINE;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
ORTHOPEDIC PROCEDURES;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
VENOUS THROMBOSIS;
WARFARIN;
|
|
EID: 3042604799
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
